Skip Nav Destination
Issues
Clinical Care/Education/Nutrition
A Controlled Evaluation of Staging Dietary Patterns to Reduce the Risk of Diabetes in African-American Women
Wendy Auslander, PHD; Debra Haire-Joshu, PHD; Cheryl Houston, PHD, RD; Chaie-Won Rhee, MSW; James Herbert Williams, PHD
Diabetes Care May 2002, Vol.25, 809-814. doi:https://doi.org/10.2337/diacare.25.5.809
Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials: Evidence that rosiglitazone does not cause hepatic dysfunction
Diabetes Care May 2002, Vol.25, 815-821. doi:https://doi.org/10.2337/diacare.25.5.815
Five-Week, Low–Glycemic Index Diet Decreases Total Fat Mass and Improves Plasma Lipid Profile in Moderately Overweight Nondiabetic Men
Clara Bouché, MD; Salwa W. Rizkalla, MD, PHD; Jing Luo, MD, PHD; Hubert Vidal, PHD; Annie Veronese, MB; Nathalie Pacher, MB; Caroline Fouquet, RN; Vincent Lang, PHD; Gérard Slama, MD
Diabetes Care May 2002, Vol.25, 822-828. doi:https://doi.org/10.2337/diacare.25.5.822
Epidemiology/Health Services/Psychosocial Research
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity and Lifestyle Study
David W. Dunstan, PHD; Paul Z. Zimmet, MD; Timothy A. Welborn, PHD; Maximilian P. de Courten, MD; Adrian J. Cameron, MPH; Richard A. Sicree, MPH; Terry Dwyer, PHD; Stephen Colagiuri, MD; Damien Jolley, MSC; Matthew Knuiman, PHD; Robert Atkins, MD; Jonathan E. Shaw, MD; On Behalf of the AusDiab Steering Committee
Diabetes Care May 2002, Vol.25, 829-834. doi:https://doi.org/10.2337/diacare.25.5.829
Hostility, Race, and Glucose Metabolism in Nondiabetic Individuals
Richard S. Surwit, PHD; Redford B. Williams, MD; Ilene C. Siegler, PHD; James D. Lane, PHD; Michael Helms, PHD; Katherine L. Applegate, PHD; Nancy Zucker, PHD; Mark N. Feinglos, MD; Cynthia M. McCaskill, MSN; John C. Barefoot, PHD
Diabetes Care May 2002, Vol.25, 835-839. doi:https://doi.org/10.2337/diacare.25.5.835
The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: Evidence for earlier disease manifestation
Ilse Weets, MD; Ivo H. De Leeuw, MD, PHD; Marc V.L. Du Caju, MD, PHD; Raoul Rooman, MD; Bart Keymeulen, MD, PHD; Chantal Mathieu, MD, PHD; Raoul Rottiers, MD; Jean-Claude Daubresse, MD; Danielle Rocour-Brumioul, MD; Daniel G. Pipeleers, MD, PHD; Frans K. Gorus, MD, PHD; The Belgian Diabetes Registry
Diabetes Care May 2002, Vol.25, 840-846. doi:https://doi.org/10.2337/diacare.25.5.840
Gestational Diabetes Mellitus in Women of Single Gravidity in Tianjin City, China
Xilin Yang, PHD; Bridget Hsu-Hage, MS, PHD; Hong Zhang, MD; Lichun Yu, MD; Ling Dong, MD; Jingchun Li, MD; Ping Shao, MD; Changjun Zhang, MD
Diabetes Care May 2002, Vol.25, 847-851. doi:https://doi.org/10.2337/diacare.25.5.847
Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: A 10-year prospective observational study
Diabetes Care May 2002, Vol.25, 859-864. doi:https://doi.org/10.2337/diacare.25.5.859
Predisposition to Atopic Symptoms to Inhaled Antigens May Protect From Childhood Type 1 Diabetes
Petri S. Mattila, MD; Jussi Tarkkanen, MD; Harri Saxen, MD; Janne Pitkäniemi, MSC; Marjatta Karvonen, PHD; Jaakko Tuomilehto, MD; the Childhood Diabetes in Finland (DiMe) Study Group
Diabetes Care May 2002, Vol.25, 865-868. doi:https://doi.org/10.2337/diacare.25.5.865
Emerging Treatments and Technologies
Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes
Bo Ahrén, MD, PHD; Erik Simonsson, MD; Hillevi Larsson, MD, PHD; Mona Landin-Olsson, MD, PHD; Hlin Torgeirsson, MD; Per-Anders Jansson, MD, PHD; Madeléne Sandqvist, MD; Peter Båvenholm, MD, PHD; Suad Efendic, MD, PHD; Jan W. Eriksson, MD, PHD; Sheila Dickinson, MSC; David Holmes, MD
Diabetes Care May 2002, Vol.25, 869-875. doi:https://doi.org/10.2337/diacare.25.5.869
Pathophysiology/Complications
Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes
Anders Lindholm, MD, PHD; Lisbeth B. Jensen, MSC, PHD; Philip D. Home, DM, DPHIL; Philip Raskin, MD; Bernhard O. Boehm, MD, PHD; Jacob Råstam, BSC; for the European and North American Study Groups on Insulin Aspart
Diabetes Care May 2002, Vol.25, 876-882. doi:https://doi.org/10.2337/diacare.25.5.876
Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes
Kjeld Hermansen, MD, DMSC; Michele Colombo, MD; Heidi Storgaard, MD; Anette Østergaard, MSC PHARM; Klaus Kølendorf, MD; Sten Madsbad, MD
Diabetes Care May 2002, Vol.25, 883-888. doi:https://doi.org/10.2337/diacare.25.5.883
Do Sensor Glucose Levels Accurately Predict Plasma Glucose Concentrations During Hypoglycemia and Hyperinsulinemia?
Teresa P. Monsod, MD; Daniel E. Flanagan, MRCP; Fran Rife, RN; Rebecca Saenz, BS; Sonia Caprio, MD; Robert S. Sherwin, MD; William V. Tamborlane, MD
Diabetes Care May 2002, Vol.25, 889-893. doi:https://doi.org/10.2337/diacare.25.5.889
UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes
Amanda I. Adler, MD, PHD; Richard J. Stevens, PHD; Andrew Neil, FRCP; Irene M. Stratton, MSC; Andrew J. M. Boulton, FRCP; Rury R. Holman, FRCP; for the U.K. Prospective Diabetes Study Group
Diabetes Care May 2002, Vol.25, 894-899. doi:https://doi.org/10.2337/diacare.25.5.894
Renal Outcome in Type 2 Diabetic Patients With or Without Coexisting Nondiabetic Nephropathies
Teresa Yuk Hwa Wong, MRCP; Paul Cheung Lung Choi, FRCPA; Chun Cheuk Szeto, MRCP; Ka Fai To, FRCPA; Nelson Leung Sang Tang, FRCPA; Anthony Wing Hung Chan, BMSC; Philip Kam Tao Li, FRCP; Fernand Mac-Moune Lai, FRCPA
Diabetes Care May 2002, Vol.25, 900-905. doi:https://doi.org/10.2337/diacare.25.5.900
Impact of Simultaneous Pancreas and Kidney Transplantation on Progression of Coronary Atherosclerosis in Patients With End-Stage Renal Failure due to Type 1 Diabetes
J. Wouter Jukema, MD, PHD; Yves F. C. Smets, MD; Johan W. van der Pijl, MD, PHD; Aeilko H. Zwinderman, MD, PHD; Hubert W. Vliegen, MD, PHD; Jan Ringers, MD; Johan H. C. Reiber, PHD; Herman H. P. J. Lemkes, MD, PHD; Ernst E. van der Wall, MD, PHD; Johan W. de Fijter, MD, PHD
Diabetes Care May 2002, Vol.25, 906-911. doi:https://doi.org/10.2337/diacare.25.5.906
Delayed Gastric Emptying and Gastric Autoimmunity in Type 1 Diabetes
Christophe E.M. De Block, MD; Ivo H. De Leeuw, MD, PHD; Paul A. Pelckmans, MD, PHD; Dirk Callens; Emöke Máday, MSC, PHD; Luc F. Van Gaal, MD, PHD
Diabetes Care May 2002, Vol.25, 912-917. doi:https://doi.org/10.2337/diacare.25.5.912
Influence of Cardiac Autonomic Neuropathy on Heart Rate Dependence of Ventricular Repolarization in Diabetic Patients
Paul E. Valensi, MD; Nicolas B. Johnson, MD; Pierre Maison-Blanche, MD; Fabrice Extramania, MD, PHD; Gilbert Motte, MD; Philippe Coumel, MD
Diabetes Care May 2002, Vol.25, 918-923. doi:https://doi.org/10.2337/diacare.25.5.918
Reviews/Commentaries/Position Statements
The Epidemiology of Complications
Diabetes Care May 2002, Vol.25, 924-932. doi:https://doi.org/10.2337/diacare.25.5.924
Letters: Observations
What Is the Sensitivity and Specificity of Self-Report for Retinopathy Screening?
Diabetes Care May 2002, Vol.25, 933-934. doi:https://doi.org/10.2337/diacare.25.5.933
Association Between Twin Pregnancy and Hyperglycemia in a Multiethnic Community in New Zealand
Diabetes Care May 2002, Vol.25, 934-935. doi:https://doi.org/10.2337/diacare.25.5.934
A Case of Fulminant Type 1 Diabetes With Elevated Rheumatoid Factor and the Temporal Presence of Thyroid-Stimulating Hormone Receptor Antibody
Shinji Sakaue, MD; Megumi Nagata, MD; Osamu Wakabayashi, MD; Toshiro Honda, MD; Haruhiko Yoshimura, MD; Etsuro Yamaguchi, MD; Masaharu Nishimura, MD
Diabetes Care May 2002, Vol.25, 935-936. doi:https://doi.org/10.2337/diacare.25.5.935
Difference in the Relation Between Urinary Albumin Excretion and Carotid Intima-Media Thickness in Nondiabetic and Type 2 Diabetic Subjects
Gilles F.H. Diercks, MD; Erik S.G. Stroes, MD, PHD; Ad J. van Boven, MD, PHD; Arie M. van Roon, PHD; Hans L. Hillege, MD; Paul E. de Jong, MD, PHD; Andries J. Smit, MD, PHD; Rijk O.B. Gans, MD, PHD; Harry J.G.M. Crijns, MD, PHD; Ton J. Rabelink, MD, PHD; Wiek H. van Gilst, PHD
Diabetes Care May 2002, Vol.25, 936-937. doi:https://doi.org/10.2337/diacare.25.5.936
Correlation of Serum Leptin Levels With Insulin Sensitivity in Patients With Chronic Hepatitis-C Infection
Diabetes Care May 2002, Vol.25, 937. doi:https://doi.org/10.2337/diacare.25.5.937
Letters: Comments and Responses
Insulin Sensitivity Does Not Account for Differences in Type 2 Diabetes Incidence Between San Antonio, Texas and Mexico City, Mexico
James P. Burke, PHD; Ken Williams, MS; Steven M. Haffner, MD; Clicerio Gonzalez Villalpando, MD, FACP; Michael P. Stern, MD
Diabetes Care May 2002, Vol.25, 938-939. doi:https://doi.org/10.2337/diacare.25.5.938
On Methods and Materials: Response to Parretti et al.
Diabetes Care May 2002, Vol.25, 939-940. doi:https://doi.org/10.2337/diacare.25.5.939
Response to Letter by Sacks
Diabetes Care May 2002, Vol.25, 940-941. doi:https://doi.org/10.2337/diacare.25.5.940
Diabetes Care: Interventions in the Community
Diabetes Care May 2002, Vol.25, 941. doi:https://doi.org/10.2337/diacare.25.5.941
Response to Shandro et al.
Diabetes Care May 2002, Vol.25, 941-942. doi:https://doi.org/10.2337/diacare.25.5.941-a
Tribute
John B. O’Sullivan: A Pioneer in the Study of Gestational Diabetes
Diabetes Care May 2002, Vol.25, 943-944. doi:https://doi.org/10.2337/diacare.25.5.943
Key Global Literature
Key Global Literature
Diabetes Care May 2002, Vol.25, 945-946. doi:https://doi.org/10.2337/diacare.25.5.945
